Healthcare entity
Every one of those 1 sits in a single category, medical-devices. Timothy Moran is most often covered alongside Alfred Ford Jr., which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window.
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, medical-devices. Timothy Moran is most often covered alongside Alfred Ford Jr., which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. At 5, the average consequence score sits below the same-window beat average of 5.2. We currently track 1 Healthcare story that mention Timothy Moran, all published on August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Timothy Moran. Shared-story counts are live from our verified record — not editorial picks.
Timothy Moran sells 2,380 shares
Average price of $23.76 for $56,548.80; stake falls 3.46% to 66,345 shares. Sale to cover tax withholding obligations.
KMTS stock rises
Shares trade up $1.16 to $23.99 with 373,728 shares of volume versus a 404,856 average.
Alfred Ford Jr. sells 8,681 shares
Average price of $22.61 for $196,277.41; stake falls 6.81% to 118,854 shares. Sale to cover tax withholding obligations.
Kestra reports quarterly earnings
Revenue of $28.64 million; EPS of -$0.67 missed consensus of -$0.59. Analysts forecast full-year EPS of -$2.29.
Two Kestra Medical Technologies insiders disclosed routine tax-withholding sales totaling 11,061 shares after a July earnings report that missed consensus. The transactions highlight equity-vesting mechanics, but the company's negative margins and projected losses are a more consequential signal for healthcare partners assessing vendor sustainability.
Source: dailypolitical.com · tickerreport.com
Timothy Moran is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
